Free Trial

Hyperfine Q3 2024 Earnings Report

Hyperfine logo
$1.10 +0.10 (+10.00%)
As of 01/31/2025 04:00 PM Eastern

Hyperfine EPS Results

Actual EPS
-$0.14
Consensus EPS
-$0.14
Beat/Miss
Met Expectations
One Year Ago EPS
-$0.15

Hyperfine Revenue Results

Actual Revenue
$3.64 million
Expected Revenue
$3.40 million
Beat/Miss
Beat by +$240.00 thousand
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q3 2024
Time
After Market Closes

Conference Call Resources

Hyperfine Earnings Headlines

NeuroPace appoints Scott Huennekens to board
Is this Elon’s true agenda?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them
Hyperfine announces new distribution partnerships in EMEA
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR), a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

View Hyperfine Profile

More Earnings Resources from MarketBeat